Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. - Wikidata - wikimedia - TriplyDB

Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.

Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.

http://www.wikidata.org/entity/Q35053428

about

Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeutics Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.Infrequent p53 gene mutation but UV gradient-like p53 protein positivity in keloids.Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands.Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach Bench-to-bedside review: circulating microparticles--a new player in sepsis?The immunologic revolution: photoimmunology Platelet-activating factor does not mediate UVB-induced local immune suppression Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects.Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists Dietary agents in cancer prevention: an immunological perspective Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response.Sunlight and skin cancer: lessons from the immune system Suppression of an established immune response by UVA--a critical role for mast cells.Waveband and dose dependency of sunlight-induced immunomodulation and cellular changes.Serotonin signalling is crucial in the induction of PUVA-induced systemic suppression of delayed-type hypersensitivity but not local apoptosis or inflammation of the skin.UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system.Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species.An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation Platelet activating factor-induced expression of p21 is correlated with histone acetylation Psoralen Inhibited Apoptosis of Osteoporotic Osteoblasts by Modulating IRE1-ASK1-JNK Pathway.Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane.Challenge and perspective: the relevance of ultraviolet (UV) radiation and the vitamin D endocrine system (VDES) for psoriasis and other inflammatory skin diseases.The Ability of Extracellular Vesicles to Induce a Pro-Inflammatory Host Response.The Skin Microbiome: Is It Affected by UV-induced Immune Suppression?Desired response to phototherapy vs photoaggravation in psoriasis: what makes the difference?STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.Phototherapeutic hardening modulates systemic cytokine levels in patients with polymorphic light eruption.Extracorporeal photochemotherapy as systemic monotherapy of severe, refractory atopic dermatitis: results from a prospective trial.Psoralen and Ultraviolet A Light Treatment Directly Affects Phosphatidylinositol 3-Kinase Signal Transduction by Altering Plasma Membrane Packing.Topical liposomal DNA-repair enzymes in polymorphic light eruption.A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells.Photohardening restores the impaired neutrophil responsiveness to chemoattractants leukotriene B4 and formyl-methionyl-leucyl-phenylalanin in patients with polymorphic light eruption From Early Immunomodulatory Triggers to Immunosuppressive Outcome: Therapeutic Implications of the Complex Interplay Between the Wavebands of Sunlight and the Skin

P2860

Q28486298-05E34C6D-9925-417B-BEE1-F85AC6F6EA93 Q33896449-F3093BFE-E3DB-4296-85CE-BB8F1702430C Q34149803-1C6B67E6-3CCC-422C-ADFA-BBBCF4F02342 Q34195303-226FDC2E-C53E-4579-9762-C7A549FA4EE7 Q34716311-E766E708-C832-4D56-94B9-98F0C7D4A360 Q34760824-F4BE9592-EAD9-464F-87A6-F0F38329740D Q35206870-5D5E41DB-8D24-4916-A5C9-3B938E74C729 Q35559151-B2E9FC79-595C-438B-A6C6-C09F347973B3 Q35757325-58DD76D0-1B3D-4A0B-AE1A-331FD18AD542 Q35798982-A4FA008F-EA58-4BD4-A484-9CFA9D6ED1D0 Q35932617-F10EFB0E-A918-4348-BCDD-C3AC1F8F3E3D Q36346908-1F10D25B-85DE-497F-BB35-98DFA75560D2 Q36625266-F06B619C-7B10-412D-A6DE-2D6321389B70 Q36668031-1D31D37A-879C-492A-B0B6-2E7250F412B1 Q36672250-01A56C39-27F2-4536-9F83-41D4BB2282D3 Q36678589-70AC32D1-16C2-490C-BFFE-10B2328211ED Q36690927-4C4897C1-D2CF-44F5-9712-244955538FF7 Q36795439-4462EB27-75E8-4412-8C62-BE1DF3F854D5 Q36836197-9502F18A-9F5C-4260-9087-BB91929509D4 Q37049515-145059D9-955F-4433-A014-DEAA4F555EEA Q37053020-7365DB82-6A5C-42A6-BF31-32BD5EB26B7D Q37098670-60D6558F-9352-4E4D-8657-71F6AF200B15 Q37156655-27DF73CE-61F5-4970-BEED-1FD4FCF48B6A Q37361204-73081E38-6C58-4C1A-A0C8-D954954212AE Q37403748-DAF33A91-53E5-4D4E-A48F-9705F71F4B14 Q37623684-A9E18CD0-4D89-476B-A6A3-150886618532 Q37703411-92DDE86A-E4B8-45CE-89F1-F781EC1266F4 Q37717757-44A31240-9100-4412-99AC-BD5DFE8F9A1E Q39067901-0357DA57-5C05-469D-AB18-3B60A757F78F Q39378240-7D59D8BF-8766-4142-8198-670B42594660 Q40563634-77F264ED-F87D-48F0-ACF1-B9C0A042B1D7 Q40626002-4FE7BE5D-5215-478B-A6C3-26E6FFB3C92E Q40802496-950A7D24-552E-4FBB-9CC6-9F07CAECAD53 Q43740154-C75ACA42-86EB-4E6B-9598-76213F643537 Q48392689-A893549B-D6FF-4B5E-8407-1FB7E84639FB Q49150858-41E15384-B6D8-470A-A729-125880CFCCC8 Q50279530-5109953F-8CEC-4386-AB56-70BC6F085DCC Q55106781-67CF02DB-94D6-4274-98AA-D08769B53AAA Q55173973-9B4A5750-E786-45F5-BC86-8EB42E17354E Q57158943-873BD104-6720-4551-8654-57F3756BFC8B

P2860

Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.

http://www.wikidata.org/entity/Q35053428

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Platelet-activating factor is ...... , inflammation, and apoptosis.

@ast

Platelet-activating factor is ...... , inflammation, and apoptosis.

@en

type

label

Platelet-activating factor is ...... , inflammation, and apoptosis.

@ast

Platelet-activating factor is ...... , inflammation, and apoptosis.

@en

prefLabel

Platelet-activating factor is ...... , inflammation, and apoptosis.

@ast

Platelet-activating factor is ...... , inflammation, and apoptosis.

@en

P1433

Q35053428-E71F4AEF-684A-4AFA-BEF1-1711688FCED5

P1476

Q35053428-3EC3BDD9-145D-4F93-B1A8-4B4DCF8F78A6

P2093

Q35053428-03BA567D-81D6-4957-BD9C-A39BC6E1AA1F

Q35053428-08D03308-F5AC-49DE-BE43-8253175678BD

Q35053428-1EDE53F3-D511-4BCC-9FFF-DFB5790019F1

Q35053428-5A9A2A6D-9CB3-44D6-9AAA-0CB9A02CFD03

Q35053428-80AE034A-1413-4816-8B47-3F14D08D84E6

Q35053428-FA27E6AD-E459-4F66-858A-7E2C7423910B

Q35053428-FA9912EC-049C-4B35-8CC4-60B79ADFEA3C

Q35053428-FD77E0D3-C5C4-4B99-99F6-8222F2395F24

P2860

Q35053428-0035AAC7-521C-4A26-B24A-2DA6E11F2376

Q35053428-00DDB9A6-0679-4BCE-9DAA-0FAEE1F95658

Q35053428-0411A4D2-B888-4640-B5DF-56631CDC5622

Q35053428-07DA7421-ACC1-4C70-9C96-946E8E0C602F

Q35053428-0964D35E-755B-447B-BF72-68C0B2BB0D97

Q35053428-0EE204F5-78CA-4C25-A57B-724F6C12D22A

Q35053428-1808570A-3A78-42D3-87D2-08B7D7C2A599

Q35053428-1E7CA7A3-3FB7-44F0-812D-FA692C2E930C

Q35053428-21E96685-8695-4C42-ACAF-52E366E7A41D

Q35053428-24D296E6-AF4B-4A7C-A9D5-6EA929B32419

P304

Q35053428-56BE19D0-7B85-4AA5-A75D-4299CA78357A

P31

Q35053428-DC9C48E0-CA54-4915-A4E6-C35630255D59

P356

Q35053428-97B474BD-AD9C-4480-B2B9-4102F214336B

P407

Q35053428-FCA14B89-B545-48F5-B737-6C41B0D2914F

P433

Q35053428-DB52BECB-5597-4182-BDED-3E3D10AF5295

P478

Q35053428-8E9360EB-A521-48E7-A26A-8D1D4A3EE684

P50

Q35053428-BEDD14AE-7A3C-47D0-AAED-8098DBF6600C

P577

Q35053428-D6D50CF9-E872-4369-AB6D-C6390173FDB9

P5875

Q35053428-CC5EE24B-154D-4B8C-9437-78E6726A5D2D

P698

Q35053428-10145A5F-CE85-44EF-B764-EA98BA808DD6

P932

Q35053428-07605C2D-C9D6-48CD-9312-D8AEEA488723

P356

AJPATH.2006.060079

P1433

The American Journal of Pathology

P1476

Platelet-activating factor is ...... n, inflammation, and apoptosis

@en

P2093

Cora Bucana

http://www.w3.org/2001/XMLSchema#string

Dat X Nghiem

http://www.w3.org/2001/XMLSchema#string

Honnavara N Ananthaswamy

http://www.w3.org/2001/XMLSchema#string

Jeffrey P Walterscheid

http://www.w3.org/2001/XMLSchema#string

Peter Wolf

http://www.w3.org/2001/XMLSchema#string

Stephen E Ullrich

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Matsumura

http://www.w3.org/2001/XMLSchema#string

Yumi Matsumura

http://www.w3.org/2001/XMLSchema#string

P2860

cPLA2 is phosphorylated and activated by MAP kinase

Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase

Effects of Calaguala and an active principle, adenosine, on platelet activating factor

Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

Identification of platelet-activating factor acetylhydrolase II in human skin.

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.

Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.

A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.

P304

795-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2006.060079

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6852835

http://www.w3.org/2001/XMLSchema#string

P698

16936256

http://www.w3.org/2001/XMLSchema#string

P932

1579250

http://www.w3.org/2001/XMLSchema#string